Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bas W G van Rhijn

Showing results (41-50 of 215) with videos related to

Pageof 22
Sort By:
Plos One|November 13, 2010
FGFR3, HRAS, KRAS, NRAS and PIK3CA mutations in bladder cancer and their potential as biomarkers for surveillance and therapyLucie C Kompier, Irene Lurkin, Madelon N M van der Aa, et al.
The Journal of Urology|November 13, 2012
FDG-positron emission tomography/computerized tomography for monitoring the response of pelvic lymph node metastasis to neoadjuvant chemotherapy for bladder cancerLaura S Mertens, Annemarie Fioole-Bruining, Bas W G van Rhijn, et al.
European Urology Focus|January 10, 2024
The Financial Burden of Guideline-recommended Cancer Medications for Metastatic Urothelial CarcinomaRoberto Contieri, Alberto Martini, Laura S Mertens, et al.
World Journal of Urology|March 10, 2018
Sarcopenia predicts 90-day mortality and postoperative complications after radical cystectomy for bladder cancerRoman Mayr, Hans-Martin Fritsche, Florian Zeman, et al.
Cancer Research|March 18, 2004
FGFR3 and P53 characterize alternative genetic pathways in the pathogenesis of urothelial cell carcinomaBas W G van Rhijn, Theo H van der Kwast, André N Vis, et al.
European Urology|April 2, 2003
Surveillance with microsatellite analysis of urine in bladder cancer patients treated by radiotherapyBas W G van Rhijn, Marij Smit, Danielle van Geenen, et al.
Current Opinion in Urology|July 24, 2020
18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in muscle-invasive bladder cancerSarah M H Einerhand, Erik J van Gennep, Laura S Mertens, et al.
Clinical Genitourinary Cancer|March 20, 2025
Survival in Responders and Nonresponders of Neoadjuvant and Induction Chemotherapy in Invasive Urothelial Carcinoma of the Urinary Bladder: A Clinical and Pathological Stage-Matched AnalysisDaan J Reesink, Charlotte S Voskuilen, Ewoudt M W van de Garde, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2003
Combined microsatellite and FGFR3 mutation analysis enables a highly sensitive detection of urothelial cell carcinoma in voided urineBas W G van Rhijn, Irene Lurkin, Dominique K Chopin, et al.
BJU International|July 12, 2025
Sentinel lymph node staging in urological cancer surgery: advances in imaging, intra-operative detection and translational researchErik J van Gennep, Gijs H KleinJan, Teele Kuusk, et al.
Pageof 22

Showing results (41-50 of 215) with videos related to

Sort By:
Pageof 22
Plos One|November 13, 2010
FGFR3, HRAS, KRAS, NRAS and PIK3CA mutations in bladder cancer and their potential as biomarkers for surveillance and therapyLucie C Kompier, Irene Lurkin, Madelon N M van der Aa, et al.
The Journal of Urology|November 13, 2012
FDG-positron emission tomography/computerized tomography for monitoring the response of pelvic lymph node metastasis to neoadjuvant chemotherapy for bladder cancerLaura S Mertens, Annemarie Fioole-Bruining, Bas W G van Rhijn, et al.
European Urology Focus|January 10, 2024
The Financial Burden of Guideline-recommended Cancer Medications for Metastatic Urothelial CarcinomaRoberto Contieri, Alberto Martini, Laura S Mertens, et al.
World Journal of Urology|March 10, 2018
Sarcopenia predicts 90-day mortality and postoperative complications after radical cystectomy for bladder cancerRoman Mayr, Hans-Martin Fritsche, Florian Zeman, et al.
Cancer Research|March 18, 2004
FGFR3 and P53 characterize alternative genetic pathways in the pathogenesis of urothelial cell carcinomaBas W G van Rhijn, Theo H van der Kwast, André N Vis, et al.
European Urology|April 2, 2003
Surveillance with microsatellite analysis of urine in bladder cancer patients treated by radiotherapyBas W G van Rhijn, Marij Smit, Danielle van Geenen, et al.
Current Opinion in Urology|July 24, 2020
18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in muscle-invasive bladder cancerSarah M H Einerhand, Erik J van Gennep, Laura S Mertens, et al.
Clinical Genitourinary Cancer|March 20, 2025
Survival in Responders and Nonresponders of Neoadjuvant and Induction Chemotherapy in Invasive Urothelial Carcinoma of the Urinary Bladder: A Clinical and Pathological Stage-Matched AnalysisDaan J Reesink, Charlotte S Voskuilen, Ewoudt M W van de Garde, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2003
Combined microsatellite and FGFR3 mutation analysis enables a highly sensitive detection of urothelial cell carcinoma in voided urineBas W G van Rhijn, Irene Lurkin, Dominique K Chopin, et al.
BJU International|July 12, 2025
Sentinel lymph node staging in urological cancer surgery: advances in imaging, intra-operative detection and translational researchErik J van Gennep, Gijs H KleinJan, Teele Kuusk, et al.
Pageof 22